Arama Sonuçları - Shi-Ming Lin

Management Consensus Guidelines for Hepatocellular Carcinoma: 2023 Update on Surveillance, Diagnosis, Systemic Treatment, and Posttreatment Monitoring by the Taiwan Liver Cancer As... Yazar: Wei Teng, Hung-Wei Wang, Shi-Ming Lin

Tam Metin Erişim

Hepatocellular carcinoma systemic treatment update: From early to advanced stage Yazar: Wei Teng, Tai-Chi Wu, Shi-Ming Lin

Tam Metin Erişim

HURP expression-assisted risk scores identify prognosis distinguishable subgroups in early stage liver cancer. Yazar: Ming-Ling Chang, Shi-Ming Lin, Chau-Ting Yeh

Tam Metin Erişim

AXL and MET in Hepatocellular Carcinoma: A Systematic Literature Review Yazar: Chih-Hung Hsu, Yi-Hsiang Huang, Shi-Ming Lin, Chiun Hsu

Tam Metin Erişim

Combining radiofrequency ablation and ethanol injection may achieve comparable long-term outcomes in larger hepatocellular carcinoma (3.1–4 cm) and in high-risk locations Yazar: Ji-Wei Lin, Chen-Chun Lin, Wei-Ting Chen, Shi-Ming Lin

Tam Metin Erişim

Radiofrequency ablation assisted by real-time virtual sonography for hepatocellular carcinoma inconspicuous under sonography and high-risk locations Yazar: Cheng-Han Lee, Wei-Ting Chen, Chen-Chun Lin, Wei Teng, Shi-Ming Lin, Cheng-Tang Chiu

Tam Metin Erişim

Comparison of the elecsys HBsAg II assay and the architect assay for quantification of hepatitis B surface antigen in chronic hepatitis B patients Yazar: Chen-Chih Liao, Chao-Wei Hsu, Po-Wen Gu, Chau-Ting Yeh, Shi-Ming Lin, Cheng-Tang Chiu

Tam Metin Erişim

An occult hepatitis B-derived hepatoma cell line carrying persistent nuclear viral DNA and permissive for exogenous hepatitis B virus infection. Yazar: Chih-Lang Lin, Rong-Nan Chien, Shi-Ming Lin, Po-Yuan Ke, Chen-Chun Lin, Chau-Ting Yeh

Tam Metin Erişim

Soluble form of CTLA‐4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patients Yazar: Wei Teng, Wen‐Juei Jeng, Wei‐Ting Chen, Chen‐Chun Lin, Chun‐Yen Lin, Shi‐Ming Lin, I‐Shyan Sheen

Tam Metin Erişim

Subsequent locoregional therapy prolongs survival in progressive hepatocellular carcinoma patients under lenvatinib treatment Yazar: Po-Ting Lin, Wei Teng, Wen-Juei Jeng, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Lin, I-Shyan Sheen

Tam Metin Erişim

Percutaneous radiofrequency ablation of tumor feeding artery before target tumor ablation may reduce local tumor progression in hepatocellular carcinoma Yazar: Ya-Ting Cheng, Wen-Juei Jeng, Chen-Chun Lin, Wei-Ting Chen, I-Shyan Sheen, Chun-Yen Lin, Shi-Ming Lin

Tam Metin Erişim

TKI plus ICI versus ICI alone in high tumor burden hepatocellular carcinoma: a retrospective cohort study Yazar: Po-Ting Lin, Wei Teng, Wei-Ting Chen, Chung-Wei Su, Yi-Chung Hsieh, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Lin

Tam Metin Erişim

Prolonged post-ablation fever may predict one-year tumor recurrence in hepatocellular carcinoma after radiofrequency ablation Yazar: Ping-Hung Ho, Wei Teng, Chen-Chun Lin, Wen-Juei Jeng, Wei-Ting Chen, Chun-Yen Lin, Shi-Ming Lin, I-Shyan Sheen

Tam Metin Erişim

Incorporation of biochemical factors for survival analysis of transarterial chemoembolization in patients with hepatocellular carcinoma: A retrospective cohort study Yazar: Wen-Hui Chan, Song-Fong Huang, Chao-Wei Lee, Tsung-Han Wu, Kuan-Tse Pan, Shi-Ming Lin, Ming-Chin Yu, Chien-Fu Hung

Tam Metin Erişim

A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectiveness. Yazar: Shen-Yen Lin, Chien-Ming Chen, Bing-Shen Huang, Ying-Chieh Lai, Kuang-Tse Pan, Shi-Ming Lin, Sung-Yu Chu, Jeng-Hwei Tseng

Tam Metin Erişim

Factors predictive of clinical outcome in advanced hepatocellular carcinoma patients receiving ramucirumab treatment: A real‐world experience Yazar: Po‐Ting Lin, Min‐Hua Hung, Shih‐Chieh Shao, Hui‐Yu Chen, Yuk‐Ying Chan, Kai‐Cheng Chang, Shi‐Ming Lin, Huang‐Tz Ou

Tam Metin Erişim

Targeted fetal NGS panel reveals genetic conditions in sonographically normal fetuses: Insights from a large cohort study. Yazar: Han-Ying Chen, Yi-Ting Wang, Jessica Kang, Yi-Yun Tai, Ti-Jia Yuan, Shin-Yu Lin, Shi-Ming Lin, Chien-Nan Lee, Tsang-Ming Ko

Tam Metin Erişim

Targeted fetal NGS panel reveals genetic conditions in sonographically normal fetuses: Insights from a large cohort study Yazar: Han-Ying Chen, Yi-Ting Wang, Jessica Kang, Yi-Yun Tai, Ti-Jia Yuan, Shin-Yu Lin, Shi-Ming Lin, Chien-Nan Lee, Tsang-Ming Ko

Tam Metin Erişim

Hepatic decompensation during paritaprevir/ritonavir/ombitasvir/dasabuvir treatment for genotype 1b chronic hepatitis C patients with advanced fibrosis and compensated cirrhosis. Yazar: Yi-Chung Hsieh, Wen-Juei Jeng, Chien-Hao Huang, Wei Teng, Wei-Ting Chen, Yi-Cheng Chen, Shi-Ming Lin, Dar-In Tai, Chun-Yen Lin, I-Shyan Sheen

Tam Metin Erişim

A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements Yazar: Masatoshi Kudo, Kwang-Hyub Han, Sheng-Long Ye, Jian Zhou, Yi-Hsiang Huang, Shi-Ming Lin, Chung-Kwe Wang, Masafumi Ikeda, Stephen Lam Chan, Su Pin Choo, Shiro Miyayama, Ann Lii Cheng

Tam Metin Erişim